日日噜夜夜草|一级黄色录像高清版|调教白富美加勒比久久|亚洲欧洲精品婷婷|日韩综合无码色色|日韩精品一区妖精视频|亚洲无码中文字幕hd|99亚洲思思丝袜|手机看片国产精品大胆亚洲|成人无码视频一区二区在线播放

更新于 8月13日

Regional Clinical Trial Submission Manager

3.5-6.5萬
  • 上海浦東新區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實(shí)力大公司

職位描述

藥企
JOB SUMMARY
The CTRSE Regional Submission Manager, is accountable for the timely and compliance delivery of Clinical Trial Applications to both Health Authorities and Central Ethics, leading project management activities for Clinical Trials, across multiple TAs, Phases and Markets. The CT RSM Provides an interface to GSSO partners, offering project leadership and expertise in the strategic and operational execution of regulatory Clinical Trial Application (CTA) submissions to regional partners and selected Health Authorities/Central Ethics Committees. This role will focus on the CTA submissions in China and other APAC countries.
The Clinical Trial Submission Manager (CT-SM) is accountable for working with contributing business lines to lead submissions execution timelines for designated CTAs. They may operate as regulatory Subject Matter Expert for a CTA and drive submission teams towards the timely delivery of globally compliant submission-ready components. The CT-SM is required to author & deliver customized documentation for selected submissions across multiple markets.
The CT-SM may be assigned as a Global Submission Manager to meet business demands. In this capacity, they may operate as Subject Matter Expert for a selected geography.
JOB RESPONSIBILITIES
● Drives Regional submission management activities for their assigned protocols. Partners with global Submission and Portfolio Manager, GSSO lines and/or third-party partners, with responsibility for representation and management of required regulatory and Central Ethics activities, standards and deliverables associated with CTA submission development and execution for designated assets and/or geographies.
● Support and leads Regional and global efforts to ensure high quality components and submissions that are compliant with industry, agency and format guidelines, regulatory strategies, policies, and timelines.
● Liaises with GSSO, regarding essential documents that cross both HA and EC submission and translation processes driving compliance and timely delivery,
● Prepare, review and submit submissions to HA/Regional CTA, in order to obtain all necessary authorizations/approvals pertaining to the clinical trial conduct.
● Manages the compilation for submission build, contributing to CTA & CE approvals and authoring documentation as required. Responsible for the co-ordination of translations for local documents required for submission.
● Acts as Subject Matter Expert for CTRSE and provides country-level intelligence on clinical trial regulatory (CTR). Ensures that local country regulatory intelligence, as it pertains to the activities of the CTR team, is maintained on the central repository, e.g. Competent Authority submission requirements.
● Promotes professional development through mentoring and motivating colleagues.
● Provides guidance to and leads CTA submissions and process improvement projects, making decisions independently.
● Drives communication and proposes refinements through collaboration with stakeholders and regulatory leaders. Serves as Pfizer CTRSE representative with Health Authority meetings, Industry discussions/ initiatives.
● Contributes to changes in policies and strategies to meet evolving business needs.
● Self-initiates assignments, developing innovative ideas to resolve complex problems and leading the execution of projects.
QUALIFICATIONS / SKILLS
SKILLS
● Significant knowledge of the drug development process, Regulatory Sciences and submission management and publishing.
● Demonstrated understanding of regional and national regulator filing guidelines and dossier requirements.
● Demonstrated ability to lead and deliver through others in a matrix model.
● Demonstrated ability to deliver swift decisions in ambiguous or urgent circumstances.
● Robust organizational management skills.
● Advanced knowledge of the processes, systems and regulatory guidance and a detailed understanding/knowledge of principles and concepts of other disciplines.
● Proven ability to embrace new technologies and processes and drive their implementation.
QUALIFICIATIONS
● A degree in Pharmacy, Life Sciences, Business or Information Technology; Minimun 6 years’ experience in clinical trials; equivalent relevant professional experience will be considered.
● Comprehensive understanding of ICH/GCP guidelines, as well as CTA regulations and process in China and other APAC countries.
● In-depth understanding and proven execution of CTA processes globally.
● Proven technical aptitude and ability to quickly learn and use new software, regulations, and quality standards.
● Familiarity with pharmaceutical organizational structures, systems, and culture is preferred.
● Fluent in both written and spoken English.
#LI-PFE
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Regulatory Affairs

工作地點(diǎn)

上海浦東新區(qū)火炬蓮花科創(chuàng)園

職位發(fā)布者

王先生/區(qū)域招聘及入職交付

昨日活躍
立即溝通
公司Logo輝瑞投資有限公司公司標(biāo)簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學(xué)和全球資源為人們提供治療方案,以延長(zhǎng)其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過程中,輝瑞始終致力于奉行嚴(yán)格的質(zhì)量、安全和價(jià)值標(biāo)準(zhǔn)。我們?cè)谌虻漠a(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達(dá)和新興市場(chǎng)的員工都在推進(jìn)人類健康,推動(dòng)疾病的預(yù)防、治療和治愈,以應(yīng)對(duì)挑戰(zhàn)我們這個(gè)時(shí)代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進(jìn)世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進(jìn)入中國市場(chǎng)。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時(shí)代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務(wù)覆蓋全國300余個(gè)城市,累計(jì)投資超過15億美元,并設(shè)立了1家先進(jìn)的生產(chǎn)設(shè)施,2個(gè)研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個(gè)領(lǐng)域的處方藥和疫苗,強(qiáng)大完善的產(chǎn)品線旨在滿足生命各階段的健康需求。
公司主頁